Real-World Characterization of Dimethyl Fumarate-Related Gastrointestinal Events in Multiple Sclerosis: Management Strategies to Improve Persistence on Treatment and Patient Outcomes

INTRODUCTION: Delayed-release dimethyl fumarate (DMF) is an effective treatment for multiple sclerosis (MS). Some patients experience gastrointestinal (GI) adverse events (AEs) that may lead to premature DMF discontinuation. This study characterized the impact of site-specific GI management strategi...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Neurol Ther
Main Authors: Min, Jinny, Cohan, Stanley, Alvarez, Enrique, Sloane, Jacob, Phillips, J. Theodore, van der Walt, Anneke, Koulinska, Irene, Fang, Fang, Miller, Catherine, Chan, Andrew
Formato: Artigo
Idioma:Inglês
Publicado: Springer Healthcare 2019
Assuntos:
Original Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6534646/
https://ncbi.nlm.nih.gov/pubmed/30706431
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40120-019-0127-2
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares